News

Two SPARK-BIH funded teams network with investors and the life science industry at the international JPM BIO Partnering Event.

We wish you SPARKling holidays and a good start in a successful new year!

Can the neurological consequences of chemotherapy be prevented?

SPARK-BIH and BMBF-funded PREPARE study investigates protective effect of lithium in breast cancer patients.

In October 2022, Dr. Tanja Rosenmund, head of SPARK-BIH, together with her team welcomed fourteen new projects to the SPARK-BIH program. She and her team are excited to support the new SPARKees to translate their innovation from bench to bedside.

We are happy to share the new High-Tech Gründerfonds podcast about SPARK-BIH

VDI/VDE Innovation Interview with EpiBlock founder and SPARK alumni Prof. Heilbronn

Newly founded company of SPARK team MyoPax receives 1.3 million Euro loan

Thank you for participating in our 2022 SPARK-BIH Call and NeuroCure/SPARK Call sessions

Charité neuroscientist Prof. Dr. Surjo Soekadar awarded with ERC Proof of Concept (ERCPoC) grant after NeuroCure/SPARK-BIH funding

EpiBlok Therapeutics GmbH is developing a gene therapy for epilepsy